A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation

R. W G Gruessner, J. P. Fryer, C. Fasola, R. E. Nakhleh, A. C. Gruessner, S. Kim, D. L. Dunn, J. Pirenne, I. Bekersky, E. Benedetti, Christoph Troppmann

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Rejection remains a major barrier to successful bowel transplantation, and immunosuppressive protocols are far from standardized. In 88 nonrelated outbred pigs, we compared the effects of two immunosuppressive regimens - one with FK506, the other with cyclosporine (CsA) and pig antithymocyte globulin (ATG)-on incidence and severity of rejection in the early, critical posttransplant period. Group A (n=14) was nonimmunosuppressed (controls). Group B (n=17) received pig ATG (10 mg/kg/day x10 days), CsA (3 mg/kg/day), prednisolone (2 mg/kg/day), and azathioprine (2.5 mg/kg/day); prednisolone and azathioprine were each reduced by 50% at 8 and 15 days posttransplant. Trough CsA whole-blood concentrations were ≥400 ng/ml for the first 7 days, ≥200 ng/ml thereafter. Group C (n=13) received FK506 (0.2 mg/kg/day) and prednisolone (2 mg/kg/day); prednisolone was reduced by 50% at 8 and 15 days. FK506 whole-blood concentrations were ≥20 ng/ml. All immunosuppression in groups B and C was given intravenously. We performed orthotopic small bowel transplants with systemic venous drainage. Recipient bowel was resected distal to the second portion of the duodenum and proximal to the rectum at transplant; bowel continuity was restored by duodenojejunostomy; ileostomy was created distally to allow access for daily biopsies. We graded interstitial and vascular rejection separately, according to a scoring system (no, mild, moderate, and severe rejection). Rejection-free graft survivals at 7, 14, and 21 days posttransplant were 38%, 19%, and 0% in group A; 93%, 93%, and 62% in group B; and 100%, 91%, and 82% in group C (P<0.001). Comparing rejection in the immunosuppressed groups, group C (FK506) had a stronger tendency toward rejection than group B (CsA-ATG); significant differences between groups B and C were, however, noted only on individual days posttransplant, not over time. The death rate due to irreversible rejection was not significantly different in groups B and C (P=0.8), but was significantly better in both of these immunosuppressed groups than in group A (P<0.001). Pig survival was significantly longer in group C than in B (P=0.001) due to a lower infection rate in group C. Posttransplant serum interleukin 2 and 7 levels did not correlate with rejection grades. Graft- versus-host reaction was noted only in the skin in 29% of group A, 73% of group B, and 77% of group C pigs; liver and native bowel were not involved. We conclude that high-dose intravenous immunosuppressive regimens-whether FK506 or CsA-ATG-can effectively prevent moderate and severe interstitial rejection in the early period after bowel transplantation.

Original languageEnglish (US)
Pages (from-to)164-171
Number of pages8
JournalTransplantation
Volume59
Issue number2
StatePublished - 1995
Externally publishedYes

Fingerprint

Antilymphocyte Serum
Tacrolimus
Prednisolone
Swine
Transplantation
Prospective Studies
Immunosuppressive Agents
Azathioprine
Transplants
Interleukin-7
Ileostomy
Graft Survival
Duodenum
Rectum
Immunosuppression
Cyclosporine
Interleukin-2
Blood Vessels
Drainage
Biopsy

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Gruessner, R. W. G., Fryer, J. P., Fasola, C., Nakhleh, R. E., Gruessner, A. C., Kim, S., ... Troppmann, C. (1995). A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. Transplantation, 59(2), 164-171.

A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. / Gruessner, R. W G; Fryer, J. P.; Fasola, C.; Nakhleh, R. E.; Gruessner, A. C.; Kim, S.; Dunn, D. L.; Pirenne, J.; Bekersky, I.; Benedetti, E.; Troppmann, Christoph.

In: Transplantation, Vol. 59, No. 2, 1995, p. 164-171.

Research output: Contribution to journalArticle

Gruessner, RWG, Fryer, JP, Fasola, C, Nakhleh, RE, Gruessner, AC, Kim, S, Dunn, DL, Pirenne, J, Bekersky, I, Benedetti, E & Troppmann, C 1995, 'A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation', Transplantation, vol. 59, no. 2, pp. 164-171.
Gruessner RWG, Fryer JP, Fasola C, Nakhleh RE, Gruessner AC, Kim S et al. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. Transplantation. 1995;59(2):164-171.
Gruessner, R. W G ; Fryer, J. P. ; Fasola, C. ; Nakhleh, R. E. ; Gruessner, A. C. ; Kim, S. ; Dunn, D. L. ; Pirenne, J. ; Bekersky, I. ; Benedetti, E. ; Troppmann, Christoph. / A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. In: Transplantation. 1995 ; Vol. 59, No. 2. pp. 164-171.
@article{a83bb8e6ed164d58b0a72196584d82ec,
title = "A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation",
abstract = "Rejection remains a major barrier to successful bowel transplantation, and immunosuppressive protocols are far from standardized. In 88 nonrelated outbred pigs, we compared the effects of two immunosuppressive regimens - one with FK506, the other with cyclosporine (CsA) and pig antithymocyte globulin (ATG)-on incidence and severity of rejection in the early, critical posttransplant period. Group A (n=14) was nonimmunosuppressed (controls). Group B (n=17) received pig ATG (10 mg/kg/day x10 days), CsA (3 mg/kg/day), prednisolone (2 mg/kg/day), and azathioprine (2.5 mg/kg/day); prednisolone and azathioprine were each reduced by 50{\%} at 8 and 15 days posttransplant. Trough CsA whole-blood concentrations were ≥400 ng/ml for the first 7 days, ≥200 ng/ml thereafter. Group C (n=13) received FK506 (0.2 mg/kg/day) and prednisolone (2 mg/kg/day); prednisolone was reduced by 50{\%} at 8 and 15 days. FK506 whole-blood concentrations were ≥20 ng/ml. All immunosuppression in groups B and C was given intravenously. We performed orthotopic small bowel transplants with systemic venous drainage. Recipient bowel was resected distal to the second portion of the duodenum and proximal to the rectum at transplant; bowel continuity was restored by duodenojejunostomy; ileostomy was created distally to allow access for daily biopsies. We graded interstitial and vascular rejection separately, according to a scoring system (no, mild, moderate, and severe rejection). Rejection-free graft survivals at 7, 14, and 21 days posttransplant were 38{\%}, 19{\%}, and 0{\%} in group A; 93{\%}, 93{\%}, and 62{\%} in group B; and 100{\%}, 91{\%}, and 82{\%} in group C (P<0.001). Comparing rejection in the immunosuppressed groups, group C (FK506) had a stronger tendency toward rejection than group B (CsA-ATG); significant differences between groups B and C were, however, noted only on individual days posttransplant, not over time. The death rate due to irreversible rejection was not significantly different in groups B and C (P=0.8), but was significantly better in both of these immunosuppressed groups than in group A (P<0.001). Pig survival was significantly longer in group C than in B (P=0.001) due to a lower infection rate in group C. Posttransplant serum interleukin 2 and 7 levels did not correlate with rejection grades. Graft- versus-host reaction was noted only in the skin in 29{\%} of group A, 73{\%} of group B, and 77{\%} of group C pigs; liver and native bowel were not involved. We conclude that high-dose intravenous immunosuppressive regimens-whether FK506 or CsA-ATG-can effectively prevent moderate and severe interstitial rejection in the early period after bowel transplantation.",
author = "Gruessner, {R. W G} and Fryer, {J. P.} and C. Fasola and Nakhleh, {R. E.} and Gruessner, {A. C.} and S. Kim and Dunn, {D. L.} and J. Pirenne and I. Bekersky and E. Benedetti and Christoph Troppmann",
year = "1995",
language = "English (US)",
volume = "59",
pages = "164--171",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation

AU - Gruessner, R. W G

AU - Fryer, J. P.

AU - Fasola, C.

AU - Nakhleh, R. E.

AU - Gruessner, A. C.

AU - Kim, S.

AU - Dunn, D. L.

AU - Pirenne, J.

AU - Bekersky, I.

AU - Benedetti, E.

AU - Troppmann, Christoph

PY - 1995

Y1 - 1995

N2 - Rejection remains a major barrier to successful bowel transplantation, and immunosuppressive protocols are far from standardized. In 88 nonrelated outbred pigs, we compared the effects of two immunosuppressive regimens - one with FK506, the other with cyclosporine (CsA) and pig antithymocyte globulin (ATG)-on incidence and severity of rejection in the early, critical posttransplant period. Group A (n=14) was nonimmunosuppressed (controls). Group B (n=17) received pig ATG (10 mg/kg/day x10 days), CsA (3 mg/kg/day), prednisolone (2 mg/kg/day), and azathioprine (2.5 mg/kg/day); prednisolone and azathioprine were each reduced by 50% at 8 and 15 days posttransplant. Trough CsA whole-blood concentrations were ≥400 ng/ml for the first 7 days, ≥200 ng/ml thereafter. Group C (n=13) received FK506 (0.2 mg/kg/day) and prednisolone (2 mg/kg/day); prednisolone was reduced by 50% at 8 and 15 days. FK506 whole-blood concentrations were ≥20 ng/ml. All immunosuppression in groups B and C was given intravenously. We performed orthotopic small bowel transplants with systemic venous drainage. Recipient bowel was resected distal to the second portion of the duodenum and proximal to the rectum at transplant; bowel continuity was restored by duodenojejunostomy; ileostomy was created distally to allow access for daily biopsies. We graded interstitial and vascular rejection separately, according to a scoring system (no, mild, moderate, and severe rejection). Rejection-free graft survivals at 7, 14, and 21 days posttransplant were 38%, 19%, and 0% in group A; 93%, 93%, and 62% in group B; and 100%, 91%, and 82% in group C (P<0.001). Comparing rejection in the immunosuppressed groups, group C (FK506) had a stronger tendency toward rejection than group B (CsA-ATG); significant differences between groups B and C were, however, noted only on individual days posttransplant, not over time. The death rate due to irreversible rejection was not significantly different in groups B and C (P=0.8), but was significantly better in both of these immunosuppressed groups than in group A (P<0.001). Pig survival was significantly longer in group C than in B (P=0.001) due to a lower infection rate in group C. Posttransplant serum interleukin 2 and 7 levels did not correlate with rejection grades. Graft- versus-host reaction was noted only in the skin in 29% of group A, 73% of group B, and 77% of group C pigs; liver and native bowel were not involved. We conclude that high-dose intravenous immunosuppressive regimens-whether FK506 or CsA-ATG-can effectively prevent moderate and severe interstitial rejection in the early period after bowel transplantation.

AB - Rejection remains a major barrier to successful bowel transplantation, and immunosuppressive protocols are far from standardized. In 88 nonrelated outbred pigs, we compared the effects of two immunosuppressive regimens - one with FK506, the other with cyclosporine (CsA) and pig antithymocyte globulin (ATG)-on incidence and severity of rejection in the early, critical posttransplant period. Group A (n=14) was nonimmunosuppressed (controls). Group B (n=17) received pig ATG (10 mg/kg/day x10 days), CsA (3 mg/kg/day), prednisolone (2 mg/kg/day), and azathioprine (2.5 mg/kg/day); prednisolone and azathioprine were each reduced by 50% at 8 and 15 days posttransplant. Trough CsA whole-blood concentrations were ≥400 ng/ml for the first 7 days, ≥200 ng/ml thereafter. Group C (n=13) received FK506 (0.2 mg/kg/day) and prednisolone (2 mg/kg/day); prednisolone was reduced by 50% at 8 and 15 days. FK506 whole-blood concentrations were ≥20 ng/ml. All immunosuppression in groups B and C was given intravenously. We performed orthotopic small bowel transplants with systemic venous drainage. Recipient bowel was resected distal to the second portion of the duodenum and proximal to the rectum at transplant; bowel continuity was restored by duodenojejunostomy; ileostomy was created distally to allow access for daily biopsies. We graded interstitial and vascular rejection separately, according to a scoring system (no, mild, moderate, and severe rejection). Rejection-free graft survivals at 7, 14, and 21 days posttransplant were 38%, 19%, and 0% in group A; 93%, 93%, and 62% in group B; and 100%, 91%, and 82% in group C (P<0.001). Comparing rejection in the immunosuppressed groups, group C (FK506) had a stronger tendency toward rejection than group B (CsA-ATG); significant differences between groups B and C were, however, noted only on individual days posttransplant, not over time. The death rate due to irreversible rejection was not significantly different in groups B and C (P=0.8), but was significantly better in both of these immunosuppressed groups than in group A (P<0.001). Pig survival was significantly longer in group C than in B (P=0.001) due to a lower infection rate in group C. Posttransplant serum interleukin 2 and 7 levels did not correlate with rejection grades. Graft- versus-host reaction was noted only in the skin in 29% of group A, 73% of group B, and 77% of group C pigs; liver and native bowel were not involved. We conclude that high-dose intravenous immunosuppressive regimens-whether FK506 or CsA-ATG-can effectively prevent moderate and severe interstitial rejection in the early period after bowel transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0028893339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028893339&partnerID=8YFLogxK

M3 - Article

C2 - 7530871

AN - SCOPUS:0028893339

VL - 59

SP - 164

EP - 171

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -